Cargando…

Clustering of Alzheimer’s and Parkinson’s disease based on genetic burden of shared molecular mechanisms

One of the visions of precision medicine has been to re-define disease taxonomies based on molecular characteristics rather than on phenotypic evidence. However, achieving this goal is highly challenging, specifically in neurology. Our contribution is a machine-learning based joint molecular subtypi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Emon, Mohammad Asif, Heinson, Ashley, Wu, Ping, Domingo-Fernández, Daniel, Sood, Meemansa, Vrooman, Henri, Corvol, Jean-Christophe, Scordis, Phil, Hofmann-Apitius, Martin, Fröhlich, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645798/ https://www.ncbi.nlm.nih.gov/pubmed/33154531 http://dx.doi.org/10.1038/s41598-020-76200-4

Ejemplares similares

Realistic simulation of virtual multi-scale, multi-modal patient trajectories using Bayesian networks and sparse auto-encoders
por: Sood, Meemansa, et al.
Publicado: (2020)

Deep learning for clustering of multivariate clinical patient trajectories with missing values
por: de Jong, Johann, et al.
Publicado: (2019)

Differences in cohort study data affect external validation of artificial intelligence models for predictive diagnostics of dementia - lessons for translation into clinical practice
por: Birkenbihl, Colin, et al.
Publicado: (2020)

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms
por: Khanna, Shashank, et al.
Publicado: (2018)

Variational Autoencoder Modular Bayesian Networks for Simulation of Heterogeneous Clinical Study Data
por: Gootjes-Dreesbach, Luise, et al.
Publicado: (2020)

PDON: Parkinson’s disease ontology for representation and modeling of the Parkinson’s disease knowledge domain
por: Younesi, Erfan, et al.
Publicado: (2015)

AI reveals insights into link between CD33 and cognitive impairment in Alzheimer’s Disease
por: Raschka, Tamara, et al.
Publicado: (2023)

Evaluating the Alzheimer's disease data landscape
por: Birkenbihl, Colin, et al.
Publicado: (2020)

PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures
por: Emon, Mohammad Asif, et al.
Publicado: (2020)

Data and sample sharing as an enabler for large-scale biomarker research and development: The EPND perspective
por: Bose, Niranjan, et al.
Publicado: (2022)

Bayesian network modeling of risk and prodromal markers of Parkinson’s disease
por: Sood, Meemansa, et al.
Publicado: (2023)

Generation of realistic synthetic data using Multimodal Neural Ordinary Differential Equations
por: Wendland, Philipp, et al.
Publicado: (2022)

Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features
por: Iyappan, Anandhi, et al.
Publicado: (2017)

Comorbidity Analysis between Alzheimer’s Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs
por: Karki, Reagon, et al.
Publicado: (2017)

A systematic approach for identifying shared mechanisms in epilepsy and its comorbidities
por: Hoyt, Charles Tapley, et al.
Publicado: (2018)

The Impact of Pathway Database Choice on Statistical Enrichment Analysis and Predictive Modeling
por: Mubeen, Sarah, et al.
Publicado: (2019)

Corrigendum: The Impact of Pathway Database Choice on Statistical Enrichment Analysis and Predictive Modeling
por: Mubeen, Sarah, et al.
Publicado: (2020)

Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases
por: Emon, Mohammad Asif Emran Khan, et al.
Publicado: (2017)

Multimodal mechanistic signatures for neurodegenerative diseases (NeuroMMSig): a web server for mechanism enrichment
por: Domingo-Fernández, Daniel, et al.
Publicado: (2017)

ADataViewer: exploring semantically harmonized Alzheimer’s disease cohort datasets
por: Salimi, Yasamin, et al.
Publicado: (2022)

Challenges of Integrative Disease Modeling in Alzheimer's Disease
por: Golriz Khatami, Sepehr, et al.
Publicado: (2020)

Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer’s Disease
por: Karki, Reagon, et al.
Publicado: (2020)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer’s disease
por: Malhotra, Ashutosh, et al.
Publicado: (2014)

Exploring novel mechanistic insights in Alzheimer’s disease by assessing reliability of protein interactions
por: Malhotra, Ashutosh, et al.
Publicado: (2015)

Leveraging the Potential of Digital Technology for Better Individualized Treatment of Parkinson's Disease
por: Fröhlich, Holger, et al.
Publicado: (2022)

BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language
por: Hoyt, Charles Tapley, et al.
Publicado: (2018)

A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer’s Disease
por: Golriz Khatami, Sepehr, et al.
Publicado: (2021)

NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's disease
por: Iyappan, Anandhi, et al.
Publicado: (2016)

Association rule mining based study for identification of clinical parameters akin to occurrence of brain tumor
por: Sengupta, Dipankar, et al.
Publicado: (2013)

Remote monitoring technologies in Alzheimer’s disease: design of the RADAR-AD study
por: Muurling, Marijn, et al.
Publicado: (2021)

On the influence of several factors on pathway enrichment analysis
por: Mubeen, Sarah, et al.
Publicado: (2022)

Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease
por: Barilar, Jelena Osmanovic, et al.
Publicado: (2020)

Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease
por: Golriz Khatami, Sepehr, et al.
Publicado: (2022)

PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
por: Mouton-Liger, Francois, et al.
Publicado: (2017)

ANMerge: A Comprehensive and Accessible Alzheimer’s Disease Patient-Level Dataset
por: Birkenbihl, Colin, et al.
Publicado: (2021)

OSIRISv1.2: A named entity recognition system for sequence variants of genes in biomedical literature
por: Furlong, Laura I, et al.
Publicado: (2008)

Is dementia research ready for big data approaches?
por: Hofmann-Apitius, Martin
Publicado: (2015)

Models and methods: a perspective of the impact of six IMI translational data-centric initiatives for Alzheimer’s disease and other neuropsychiatric disorders
por: North, Hilary, et al.
Publicado: (2023)

Nonmotor Symptoms in Parkinson's Disease in 2012: Relevant Clinical Aspects
por: Bonnet, Anne Marie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l9o22u69jgm5prpvup2hu0c4vf